Amyloidosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis
Condition:   Immunoglobulin Light-chain Amyloidosis Interventions:   Drug: Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab;   Drug: Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab Sponsor:   Air Force Military Medical University, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials

Quantitative-imaging in Cardiac Transthyretin Amyloidosis
Condition:   ATTR-CM Intervention:   Radiation: 18F-fluoride PET Sponsors:   University of Edinburgh;   British Heart Foundation;   Netherlands Heart Foundation;   Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials

Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis
Condition:   Immunoglobulin Light-chain Amyloidosis Interventions:   Drug: Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab;   Drug: Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab Sponsor:   Air Force Military Medical University, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials

Quantitative-imaging in Cardiac Transthyretin Amyloidosis
Condition:   ATTR-CM Intervention:   Radiation: 18F-fluoride PET Sponsors:   University of Edinburgh;   British Heart Foundation;   Netherlands Heart Foundation;   Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials

Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis
Condition:   Immunoglobulin Light-chain Amyloidosis Interventions:   Drug: Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab;   Drug: Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab Sponsor:   Air Force Military Medical University, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials